Oxidative stress induces Z-DNA-binding protein 1-dependent activation of microglia via mtDNA released from retinal

Jamal Saada1, Ryan J McAuley2, Michela Marcatti3

  • 1Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, Texas, USA; Department of Anesthesiology, University of Texas Medical Branch, Galveston, Texas, USA.

Insights

Oxidatively damaged mitochondrial DNA (mtDNA) activates Z-DNA-binding protein 1 (ZBP1) in retinal cells, driving inflammation in ocular diseases like glaucoma and AMD. This discovery reveals a new therapeutic target for vision loss.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Ocular pathologies like glaucoma and age-related macular degeneration involve retinal inflammation and microglial activation, leading to vision loss.
  • The precise molecular triggers for microglial activation in the retina remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying retinal inflammation and microglial activation in ocular pathologies.
  • To identify novel signaling pathways and potential therapeutic targets for vision-threatening conditions.

Main Methods:

  • Investigated the effects of chronic low-level oxidative stress on retinal pigment epithelial (RPE) cells.
  • Examined mitochondrial DNA (mtDNA) damage and its translocation to the cytoplasm.
  • Assessed the role of Z-DNA-binding protein 1 (ZBP1) in mediating inflammatory responses.
  • Analyzed extracellular vesicles (EVs) containing mtDNA fragments and their impact on microglial activation.

Main Results:

  • Chronic oxidative stress in RPE cells caused mtDNA damage and cytoplasmic translocation, activating ZBP1.
  • Activated ZBP1 triggered proinflammatory marker expression in RPE cells.
  • Extracellular vesicles containing damaged mtDNA induced a proinflammatory microglial phenotype via ZBP1 activation.

Conclusions:

  • Oxidatively damaged mtDNA acts as a signaling molecule, with ZBP1 as its intracellular receptor, initiating retinal inflammation.
  • A novel mtDNA-mediated autocrine and paracrine mechanism contributes to sustained retinal inflammation in ocular diseases.
  • Targeting the mtDNA/ZBP1 pathway presents a potential therapeutic strategy for ocular pathologies and vision loss.

Related Concept Videos